2-[[5-(4-aminoquinazolin-6-yl)thiophen-2-yl]methylamino]-N-(4-fluoro-3-hydroxyphenyl)pyridine-3-carboxamide
C25H19FN6O2S — CID 122546311
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[5-(4-aminoquinazolin-6-yl)thiophen-2-yl]methylamino]-N-(4-fluoro-3-hydroxyphenyl)pyridine-3-carboxamide
2-[[5-(4-aminoquinazolin-6-yl)thiophen-2-yl]methylamino]-N-(4-fluoro-3-hydroxyphenyl)pyridine-3-carboxamide (PubChem CID 122546311) has the molecular formula C25H19FN6O2S and a molecular weight of 486.53 g/mol. Its IUPAC name is 2-[[5-(4-aminoquinazolin-6-yl)thiophen-2-yl]methylamino]-N-(4-fluoro-3-hydroxyphenyl)pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 2-[[5-(4-aminoquinazolin-6-yl)thiophen-2-yl]methylamino]-N-(4-fluoro-3-hydroxyphenyl)pyridine-3-carboxamide |
|---|---|
| PubChem CID | 122546311 |
| Molecular Formula | C25H19FN6O2S |
| Molecular Weight | 486.53 g/mol |
| Exact Mass | 486.13 |
| IUPAC Name | 2-[[5-(4-aminoquinazolin-6-yl)thiophen-2-yl]methylamino]-N-(4-fluoro-3-hydroxyphenyl)pyridine-3-carboxamide |
| SMILES | Nc1ncnc2ccc(-c3ccc(CNc4ncccc4C(=O)Nc4ccc(F)c(O)c4)s3)cc12 |
| InChI | InChI=1S/C25H19FN6O2S/c26-19-6-4-15(11-21(19)33)32-25(34)17-2-1-9-28-24(17)29-12-16-5-8-22(35-16)14-3-7-20-18(10-14)23(27)31-13-30-20/h1-11,13,33H,12H2,(H,28,29)(H,32,34)(H2,27,30,31) |
| InChIKey | MTHGCFQGAMHQJG-UHFFFAOYSA-N |
| XLogP | 5.04 |
| TPSA | 126.05 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.53 |
| LogP ≤ 5 | 5.04 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122546311 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.